mTOR inhibitors in pediatric liver transplant recipients
ConclusionOur results suggest that mTORi can be used in pediatric LT recipients in different clinical situations, both to reinforce immunosuppressive therapy, and to reduce CNI and related toxicity.
Source: Clinics and Research in Hepatology and Gastroenterology - Category: Gastroenterology Source Type: research
More News: Cancer & Oncology | Dermatitis | Dermatology | Gastroenterology | Liver | Liver Transplant | Pediatrics | Proteinuria | Study | Toxicology | Transplant Surgery | Transplants | Urology & Nephrology